Hirsutism: Difference between revisions
Jump to navigation
Jump to search
Ochuko Ajari (talk | contribs) No edit summary |
|||
Line 17: | Line 17: | ||
==[[Hirsutism differential diagnosis|Differentiating Hirsutism from other Diseases]]== | ==[[Hirsutism differential diagnosis|Differentiating Hirsutism from other Diseases]]== | ||
==Differential Diagnosis== | |||
#Idiopathic: | |||
#*Familial, | |||
#*Possibly increased sensitivity to androgens. | |||
#variant of normal menopause. | |||
#Polycystic ovarian syndrome. | |||
#Obesity | |||
#Drugs: | |||
#*Androgens, | |||
#*Anabolic steroids, | |||
#*Methyltestosterone, | |||
#*Minoxidil, | |||
#*Diazoxide, | |||
#*Phenytoin, | |||
#*Glucocorticoids, | |||
#*Cyclosporine. | |||
#*Phenytoin, | |||
#Congenital adrenal hyperplasia. | |||
#Adrenal virilizing tumor. | |||
#Ovarian virilizing tumor: | |||
#*Arrhenoblastoma, | |||
#*Hilus cell tumor. | |||
#Pituitary adenoma. | |||
#Pregnancy | |||
#Insulin resistance | |||
#Cushing's syndrome. | |||
#Hypothyroidism (congenital and juvenile). | |||
#Acromegaly. | |||
#Androgen-secreting tumors of the ovaries | |||
#*Sertoli-Leydig cell tumors, | |||
#*Granulosa-theca cell tumors, | |||
#*Hilus-cell tumors | |||
#Hyperprolactinemia | |||
#Testicular feminization. | |||
==[[Hirsutism epidemiology and demographics|Epidemiology and Demographics]]== | ==[[Hirsutism epidemiology and demographics|Epidemiology and Demographics]]== |
Revision as of 20:39, 13 September 2017
For patient information, click here
Hirsutism Microchapters |
Diagnosis |
---|
Treatment |
Medical Therapy |
Case Studies |
Hirsutism On the Web |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [2]; Associate Editor(s)-in-Chief: Ogheneochuko Ajari, MB.BS, MS [3]
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Hirsutism from other Diseases
Differential Diagnosis
- Idiopathic:
- Familial,
- Possibly increased sensitivity to androgens.
- variant of normal menopause.
- Polycystic ovarian syndrome.
- Obesity
- Drugs:
- Androgens,
- Anabolic steroids,
- Methyltestosterone,
- Minoxidil,
- Diazoxide,
- Phenytoin,
- Glucocorticoids,
- Cyclosporine.
- Phenytoin,
- Congenital adrenal hyperplasia.
- Adrenal virilizing tumor.
- Ovarian virilizing tumor:
- Arrhenoblastoma,
- Hilus cell tumor.
- Pituitary adenoma.
- Pregnancy
- Insulin resistance
- Cushing's syndrome.
- Hypothyroidism (congenital and juvenile).
- Acromegaly.
- Androgen-secreting tumors of the ovaries
- Sertoli-Leydig cell tumors,
- Granulosa-theca cell tumors,
- Hilus-cell tumors
- Hyperprolactinemia
- Testicular feminization.
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | Chest X Ray | CT | MRI | Echocardiography or Ultrasonography | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Case Studies
Related Chapters
References
- Ferriman D, Gallwey JD: Clinical assessment of body hair growth in women. Journal of Clinical Endocrinology 1961; 21:1440-1447.
bg:Хирзутизъм
de:Hirsutismus
et:Hirsutism
id:Hirsutisme
nl:Hirsutisme